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        Introduction 
  Protein misfolding and aggregation are the common pathological 
changes in age-dependent neurodegenerative disorders (  Kopito, 
2000 ;   Goldberg,  2003 ).  Of  these  disorders,  Huntington ’ s  disease 
(HD) is caused by the expansion of a polyglutamine (polyQ) tract 
(  >  37 glutamines) in the N-terminal region of huntingtin (htt), a 
350-kD protein that is predominantly distributed in the cytoplasm 
(  Gusella and Macdonald, 2006  ). PolyQ expansion, which results 
in protein misfolding, aggregation, and cytotoxicity, also leads to 
selective neurodegeneration in distinct brain regions in eight 
other polyQ diseases (  Orr and Zoghbi, 2007  ). Unlike most polyQ 
diseases, in which mutant proteins are mainly located in the 
nucleus, HD features the accumulation of mutant htt in neuro  -
nal processes and synapses in addition to nuclear inclusions. 
Although mounting evidence indicates that nuclear mutant htt 
induces neuropathology by altering gene expression, the effect of 
mutant htt in synapses remains unclear, despite its association 
with synaptic dysfunction (  Smith et al., 2005  ;   Li and Li, 2006  ). 
  The ubiquitin  –  proteasome system (UPS) plays an essen-
tial role in degrading damaged or misfolded proteins (  Hershko 
and Ciechanover, 1998  ). Misfolded proteins and protein frag-
ments generated by proteolysis are polyubiquitinated by ubiqui-
tin ligases, a process that targets the substrates to the proteasome 
for degradation ( Demartino and Gillette, 2007 ). The 26S protea-
some, which consists of a 20S catalytic core particle and a 19S 
regulatory particle, selectively degrades ubiquitinated proteins 
(  Pickart and Cohen, 2004  ). Thus, a major aspect of UPS func-
tion is the dynamic control of protein stability, which is impor-
tant for a variety of cellular processes, including cell cycle 
control, transcription, chromatin remodeling, and protein traf-
fi  cking. Recently, the UPS has emerged as a key regulator of 
synaptic plasticity and function ( Korhonen and Lindholm, 2004 ; 
  Yi and Ehlers, 2005  ;   Patrick, 2006  ). In the presynaptic terminal, 
the UPS regulates presynaptic function through multi-ubiqui-
tination and protein turnover, thereby altering protein activity 
and vesicle dynamics (  Wilson et al., 2002  ;   Chen et al., 2003  ; 
  Speese et al., 2003  ). The UPS also critically controls postsynap-
tic remodeling and plasticity. For example, proteasomal inhibi-
tion prevents neuronal activity-regulated composition of the 
postsynaptic density (PSD) proteins (  Ehlers, 2003  ), and the 
activity-dependent endocytosis of AMPA receptors is sensitive 
to proteasome inhibition (  Colledge et al., 2003  ). 
  Cells can regulate proteasome function in response to 
changing physiological demands by altering the total number of 
proteasomes ( Lecker et al., 2006 ) and/or by altering proteasomal 
subunit composition (  Glickman and Raveh, 2005  ). The complex 
components of the proteasome, however, make it diffi  cult to in-
vestigate potential changes in a large number of proteasomal sub-
units. Also, the proteasome exists as a heterogeneous group of 
structures in different subcellular regions (  Brooks et al., 2000  ; 
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function in various cell models or in vitro systems (  Bence et al., 
2001 ;  Verhoef et al., 2002 ;  Venkatraman et al., 2004 ;  Bennett et al., 
2005  ), in vivo studies of UPS function in polyQ disease mouse 
models have not yielded consistent results (  Bowman 
et al., 2005  ;   Bett et al., 2006  ;   Bennett et al., 2007  ). These previous 
in vivo studies, however, did not examine proteasomal activity 
in different subcellular regions of neurons. Given that mutant htt 
accumulates in neuronal processes and synapses (  DiFiglia 
et al., 1997  ;   Gutekunst et al., 1999  ;   Li et al., 2000  ) and affects 
synaptic function (  Usdin et al., 1999  ;   Cepeda et al., 2001  ;   Zeron 
et al., 2002  ;   Smith et al., 2005  ;   Cummings et al., 2006  ;   Fan 
et al., 2007  ), it is important to investigate the specifi  c effect of 
mutant htt on the UPS in synaptic terminals. 
  In the present study, we targeted UPS reporters to presyn-
aptic or postsynaptic terminals. In combination with synapto-
somal fractionation and biochemical analysis, our studies 
demonstrate that mutant htt can inhibit the function of synaptic 
proteasomes. This fi  nding offers important insight into the 
mechanism by which mutant htt affects synaptic function and 
neurotransmitter release. The assays used in our studies can also 
be applied to other neurological disorder models to examine 
possible changes in synaptic UPS activities. 
  Results 
  Generation of synaptic reporters 
for UPS activity 
 The  fl  uorescent UPS reporter GFPu, which is a green fl  uo-
rescent fusion protein tagged with a CL-1 degron sequence 
(16 amino acids) specifi  c for ubiquitination and degradation by 
the proteasome, has been widely used to examine the activity of 
the proteasome in cells (  Bence et al., 2001  ;   Dong et al., 2004  ; 
  Avraham et al., 2005  ;   Bennett et al., 2005  ). To specifi  cally 
measure synaptic UPS activity using this reporter, we fused 
the postsynaptic protein PSD95 or the presynaptic protein 
SNAP25 to GFPu in order to target this reporter to postsynaptic 
or presynaptic terminals. To ensure neuronal expression, the 
fusion proteins are expressed via an adenoviral vector under 
the control of the neuronal promoter for human synapsin 1, a 
synaptic vesicle-associated protein (  Fig. 1 A  ). As controls, we 
also generated cDNAs encoding for DsRed fusion proteins 
(RFP), which provide red fl  uorescent signals but are not de-
graded rapidly by the UPS. Thus, the ratio of GFPu to RFP 
(GFPu/RFP) refl  ects the relative activity of the UPS when GFPu 
and RFP reporters are coexpressed in the same cells. 
  Using Western blotting, we fi  rst verifi  ed that these report-
ers were expressed at the correct molecular weights in HEK293 
cells (  Fig. 1 B  ). To confi  rm that the adenoviral vector we gener-
ated drives transgene expression exclusively in neurons, we in-
fected primary cultures from embryonic rat brain with adenoviral 
SNAP25-RFP and verifi  ed that this reporter was expressed in 
neurons (NeuN-positive) but not in glial cells (GFAP-positive) 
(  Fig. 1 C  ). Moreover, after injecting this viral reporter into the 
striatum of mouse brain, we also detected red fl  uorescence 
in NeuN-positive neurons but not GFAP-positive glial cells 
(  Fig. 1 D  ). Thus, both in vitro and in vivo experiments prove the 
neuronal-specifi  c expression of our adenoviral vector. 
  W  ó  jcik and DeMartino, 2003  ). Thus, functional assays of the 
proteasome with specifi   c inhibitors or substrates have been 
widely used to assess a variety of pathological conditions. Al-
though polyQ-expanded proteins were found to impair UPS 
  Figure 1.       Expression of synaptic UPS reporters in neurons.   (A) Schematic 
map of DNA constructs for expressing ﬂ  uorescent UPS reporters. RFP or 
GFPu is added to the C terminus of PSD95 or SNAP25 in an adenoviral 
vector to express fusion proteins under the control of the human synapsin 
1 promoter. (B) Western blots showing the expression of these fusion pro-
teins in HEK293 cells after adenoviral infection. (C) Expression of ﬂ  uores-
cent UPS reporters in primary cultured cortical neurons after infection with 
adenoviral SNAP25-RFP vector. SNAP25-RFP was expressed in cultured 
primary neurons (NeuN-positive) but not in cultured glial cells (GFAP-positive). 
(D) In the mouse brain striatum injected with adenoviral SNAP25-RFP 
reporter, SNAP25-RFP was also expressed in neurons, but not glial cells. 
Immunostaining for GFAP or NeuN (green), nuclear staining (blue) by Hoechst, 
and SNAP25-RFP (red) were revealed by ﬂ   uorescent microscopy. Bars, 
5   μ  m (C) and 10   μ  m (D).     1179 SYNAPTIC PROTEASOMAL ACTIVITY IN HUNTINGTON  ’  S DISEASE   •   WANG ET AL.
simple to quantify because of the defi  ned and selective fl  uo-
rescence signals in synapses. Because transgenic reporters are 
overexpressed in the cell body, however, the diffuse fl  uorescent 
signals there are less readily quantifi  ed. Despite this we were able 
to note an increased GFPu/RFP ratio in the cell body after MG132 
treatment (  Fig. 2 E  ), which was more obvious in those images 
with a shorter exposure time (Fig. S1, available at http://www.jcb
.org/cgi/content/full/jcb.200709080/DC1). Under conditions that 
allowed clear visualization of synaptic signals, we observed that 
the ratio of GFPu to RFP in synaptic puncta showed a greater in-
crease than in the cell body after inhibiting proteasomal activity 
by MG132 (  Fig. 2 E  ). Using the same approach, we confi  rmed 
that postsynaptic reporters (PSD95-GFPu/RFP) could also refl  ect 
changes in synaptic UPS activity (  Fig. 3  ). 
  The ratio of GFPu to RFP is increased by 
inhibiting UPS activity 
  Next, we wanted to verify that the reporters can be used to mea-
sure UPS activity in synapses. We fi  rst expressed these reporters 
in HEK293 cells and then treated the cells with various protea-
somal inhibitors including MG132, ALLN, and lactacystin (Lact) 
for 8 h. As expected, these inhibitors signifi  cantly increased the 
levels of GFPu compared with the RFP control reporter or tubulin 
(  Fig. 2 A  , left). Quantifi  cation of the ratio of GFPu to RFP con-
fi  rmed this increase (  Fig. 2 A  , right). We then infected cultured 
primary cortical and striatal neurons with these adenoviral vec-
tors and observed the localization of these reporters in synaptic 
structures, which are characterized by small puncta in neurites 
(  Fig. 2, B  –  D  ). The ratio of GFPu to RFP in synaptic structures is 
  Figure 2.       Presynaptic UPS reporters (SNAP25-GFPu/
-RFP) reﬂ  ect UPS activity in cultured cells.   (A) Western 
blot showing a signiﬁ  cant increase in SNAP25-GFPu, 
but not SNAP25-RFP, in HEK293 cells after inhibition 
of proteasomal activity by MG132 (10   μ  M), ALLN 
(10   μ  g/ml), or lactacystin (lact,10   μ  M) for 8 h. The ra-
tio (mean + SEM,   n   = 3) of GFPu to RFP was quantiﬁ  ed 
(right). (B and C) In cortical or striatal neurons coin-
fected with adenoviral SNAP25-RFP and SNAP25-
GFPu, the expression ratio of GFPu to RFP in synapses 
was increased after addition of MG132. Arrows 
indicate synapses. Bars, 5   μ  m. (D) Higher magniﬁ  ca-
tion showing the expression of SNAP25-GFPu in the 
synapses (arrows) of cultured cortical neurons. Bars, 
2.5   μ  m. (E) The ratio (mean + SEM   n   = 45) of GFPu/
RFP in the cell body or the synapses was analyzed. 
The ratio of GFPu to RFP signal was signiﬁ   cantly 
increased after inhibiting the proteasome with 10   μ  M 
MG132. *, P   <   0.05; **, P   <   0.01. ***, P   <   0.001 
as compared with control.     JCB • VOLUME 180 • NUMBER 6 • 2008  1180
GFPu/RFP in the synapses of HD neurons compared with wild-
type neurons (  Fig. 4 B  ). Thus, these fi  ndings indicate that syn-
aptic UPS activity is decreased in cultured neurons from HD 
mouse brains. 
  To examine whether these reporters can also refl  ect 
changes in synaptic UPS activity in the brain, we performed 
stereotaxic injection of adenoviral reporters into the striatum of 
wild-type or R6/2 mice aged 7  –  8 wk and examined their ex-
pression in brain sections 7  –  8 d after injection. SNAP25-GFPu 
was colocalized with a number of neuropil htt aggregates in 
HD mouse brains (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200709080/DC1), suggesting that mutant htt 
in neuronal processes is localized to synapses. Similar to what 
we observed in cultured neurons (  Fig. 4  ), presynaptic (  Fig. 5 A  ) 
and postsynaptic (  Fig. 5 B  ) GFPu/RFP ratios were increased in 
  Decreased UPS activity in synapses of HD 
neurons that express exon1 mutant htt 
  Having established the specifi  city of these fl  uorescent reporters 
to refl  ect synaptic UPS activity, we examined synaptic UPS ac-
tivity in cultured neurons from wild-type and R6/2 mice that 
express exon1 mutant htt with 115-150Q (  Davies et al., 1997  ). 
After culturing these neurons for 10 d, we infected them with 
adenoviral UPS reporters. 4  –  5 d later, we found that presynaptic 
SNAP25-GFPu was expressed at a lower level in synapses of 
wild-type neurons than in HD neurons (  Fig. 4   A, left), suggest-
ing that the UPS activity is higher in the former. Quantitative 
assessment of the ratio of GFPu/RFP demonstrated that the 
presynaptic ratio is greater in HD neurons than in wild-type 
neurons (  Fig. 4   A, right). Using postsynaptic UPS reporters 
(PSD95-GFPu/RFP), we also observed an increased ratio of 
  Figure 3.       Postsynaptic UPS reporters (PSD95-GFPu 
and PSD95-RFP) reﬂ  ect UPS activity in cultured cells.   
(A) Western blot showing a signiﬁ   cant increase in 
PSD95-GFPu, but not PSD95-RFP, in HEK293 cells 
after inhibition of proteasomal activity by MG132 
(10   μ  M), ALLN (10   μ  g/ml), or lactacystin (lact, 10   μ  M). 
The ratio (mean + SEM,   n   = 3) of GFPu to RFP is quan-
tiﬁ  ed (right). (B and C) In cortical or striatal neurons 
coinfected by adenoviruses of PSD95-RFP and PSD95-
GFPu, the expression ratio of GFPu to RFP in synapses 
was increased after addition of MG132. Arrows in-
dicate synapses. Bars, 5   μ  m. (D) Higher magniﬁ  ca-
tion showing the expression of PSD95-GFPu in the 
synapses (arrows) of cortical neurons. Bars, 2.5   μ  m. 
(E) The ratio (mean + SEM,   n   = 40) of GFPu to RFP 
signal was signiﬁ   cantly increased after inhibiting 
the proteasome by 10   μ  M MG132. *, P   <   0.05; **, 
P   <   0.01. ***, P   <   0.001 as compared with control.     1181 SYNAPTIC PROTEASOMAL ACTIVITY IN HUNTINGTON  ’  S DISEASE   •   WANG ET AL.
gions, we isolated synaptosomal fractions and measured their 
chymotrypsin-like activity using the small fl  uorogenic peptide 
Suc-LLVY-AMC as a substrate. Synaptosomal fractions iso-
lated from mouse brains were enriched in synaptic proteins 
such as synaptophysin but not the cytoplasmic protein GAPDH 
or the nuclear protein TFIIB (  Fig. 6 B  , top). Proteasomal core 
subunits     1i (LMP2),     5i (LMP7), and other core subunits (a5, 
a7, b1, b5i, and b7) of 20S were also present in synaptosomes, 
substantiating the presence of the proteasome in synapses. 
Comparison of chymotrypsin activity in different fractions from 
wild-type mouse brains revealed that nuclear proteasomal activ-
ity is lower than cytosolic activity and that the synaptosomes 
have the lowest activity (  Fig. 6 C  ). We then examined synapto-
somes isolated from the cortex and striatum of R6/2 mice at 4 
and 10 wk of age. EM48 immunostaining revealed oligomeric 
htt in the stacking gel on Western blots (  Fig. 6 D  ). More oligo-
meric htt was found in synaptosomes isolated from older HD 
mice than younger HD mice. These fi  ndings are consistent with 
the age-dependent increase of neuropil aggregates in R6/2 
mouse brains (  Fig. 6 A  ). 
  Consistent with a previous study that did not fi  nd any de-
crease in proteasomal activity in whole brain lysates of R6/2 
mice (  Bett et al., 2006  ), examination of the chymotrypsin-like 
the synapses of HD mouse brains compared with those of wild-
type mouse striatum. Although the ratio of GFPu/RFP in the 
cell body is not statistically different between HD and wild-
type mice, this ratio in synapses of HD neurons was signifi  -
cantly higher than that in wild-type mouse brains. In situ 
hybridization did not reveal any signifi  cant difference in the 
expression of SNAP25-GFPu transcripts between wild-type 
and R6/2 mouse brains (Fig. S3, available at http://www.jcb
.org/cgi/content/full/jcb.200709080/DC1). Thus, the increased 
GFPu/RFP ratio in HD mouse brains refl  ects decreased GFPu 
degradation in synapses. 
  Because mutant htt may affect synaptic UPS activity, we 
examined whether there is a correlation in the accumulation 
of htt in neuronal processes (or neuropil aggregates) with de-
creased synaptic UPS activity. Similar to what we observed pre-
viously (  Li et al., 1999  ), EM48 immunostaining of the striatum 
and cortex of R6/2 mice at 4 and 10 wk of age revealed a dra-
matic increase in neuropil aggregates over time (  Fig. 6 A  ).
Although the fl  uorescent UPS reporters allowed us to examine 
UPS activity in synapses, these reporters indirectly measure 
UPS activity, and their sensitivity to detect UPS activity in the 
cell body is limited by diffuse and intense fl  uorescent signals. 
To compare proteasomal activity in different subcellular re-
  Figure 4.       Expression of synaptic UPS reporters in cul-
tured primary neurons from R6/2 and wild-type mice.   
(A and B) Expression of SNAP25-GFPu/-RFP (A) and 
PSD95-GFP/-RFP (B) in cultured primary striatal neurons 
from embryonic wild-type (WT, top panels) and R6/2 
(bottom panels) mice. The levels of GFPu in neuronal pro-
cesses and synapses are higher in R6/2 neurons than in 
wild-type neurons. Right panels show the ratio (mean + SEM, 
  n   = 52) of GFPu/RFP. ***, P   <   0.01. Bars, 2.5   μ  m.     JCB • VOLUME 180 • NUMBER 6 • 2008  1182
of the endogenous mouse htt promoter and is cleaved to small 
N-terminal htt fragments. In these mice, N-terminal mutant 
htt fragments preferentially form aggregates or inclusions in 
the striatum (  Lin et al., 2001  ). Because of the weak staining 
of mouse mutant htt by EM48, we used 1C2 immunostaining 
to reveal neuropil aggregates in HD knock-in mice (  Fig. 7 A  ). 
Neuropil aggregates are less abundant than nuclear aggregates 
in HD knock-in mice, suggesting that the accumulation of 
cleaved N-terminal htt fragments in distal neuronal processes 
requires more time, perhaps because transport of mutant htt to 
nerve terminals is necessary for this accumulation. However, 
there is a signifi  cant increase of neuropil aggregates from 4 to 
12 mo (  Fig. 7 A  ), allowing us to examine whether there is a 
correlated change in synaptic UPS activity. After injection of 
adenoviral UPS reporters into the striatum of HD knock-in mice 
aged 4, 8, and 12 mo, we observed a relative increase in pre-
synaptic and postsynaptic GFPu signals in older mice (  Fig. 7, 
B and C ). Quantifi  cation of the ratio of GFPu/RFP in the synapses 
of HD mice at different ages also showed a time-dependent 
increase of this ratio, which likely refl  ects a decrease in synaptic 
activity of total cell lysates from the cortex and striatum did not 
reveal a signifi  cant difference between wild-type and R6/2 
mouse brain samples (  Fig. 6 E  , left). We therefore focused on 
the proteasomal activity in isolated synaptosomes by measuring 
their chymotrypsin-like activity. These assays revealed that 
proteasomal activity was decreased in synaptosomes isolated 
from the cortex or striatum of HD mice compared with samples 
from wild-type mice (  Fig. 6 E  , right). Striatal synaptosomes 
showed lower proteasomal activity than cortical synaptosomes 
in both wild-type and HD mice. Thus, there is an intrinsic dif-
ference in synaptic proteasome activity between the striatum 
and cortex. Also, an age-dependent decrease in synaptic protea-
somal activity occurs in the brain. 
  Decreased UPS activity in the synapses of 
HD knock-in mice 
 The  above  fi  ndings suggest that N-terminal mutant htt may im-
pair UPS activity in the synapses of HD mice. It is important 
to investigate whether this defect occurs in HD knock-in mice 
in which full-length mutant htt is expressed under the control 
  Figure 5.       Expression of synaptic UPS reporters in the 
brain striatum.   (A) Expression of presynaptic reporters 
(SNAP25-GFPu/-RFP) in the striatum of R6/2 mice at 
9 wk of age 8 d after adenoviral injection. Right pan-
els show high magniﬁ  cation graphs and quantitative 
data of the ratio (mean +SEM,   n   = 48) of GFPu/RFP 
in synapses (arrows). (B) Expression of PSD95-GFPu/
-RFP in the striatum of R6/2 mice. The high magniﬁ  ca-
tion graphs and the ratio (mean + SEM,   n   = 43) of 
GFPu/RFP are also displayed in right panels. Bars, 
5   μ  m. *, P   <   0.05.     1183 SYNAPTIC PROTEASOMAL ACTIVITY IN HUNTINGTON  ’  S DISEASE   •   WANG ET AL.
12 mo of age (  Fig. 7 E  ). A decrease in postglutamyl and trypsin-
like activity was also detected in synaptosomes from the stria-
tum of HD knock-in mice at 12 mo of age (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200709080/DC1). 
Thus, synaptic proteasomal activity is inversely correlated with 
the age-dependent accumulation of N-terminal mutant htt frag-
ments in striatal neurons (  Lin et al., 2001  ). 
  Decreased synaptic ATP in HD 
knock-in mice 
  The activity of the UPS relies on adenosine triphosphate (ATP) 
generated by mitochondria. As the transport of mitochondria in 
neuronal processes is impaired by mutant htt (  Trushina et al., 
2004  ;   Chang et al., 2006  ), we explored the possibility that the 
defect in UPS activity seen in HD synapses is associated with a 
lower level of ATP in synapses. Electron microscopic examination 
revealed the presence of organelles with disrupted structures 
UPS activity (  Fig. 7 D  ). To confi  rm this increase, we used a 
biochemical assay to examine the chymotrypsin activity of iso-
lated synaptosomes in HD and age-matched wild-type mice. 
Examining proteasomal activity in whole cell extracts did not 
reveal signifi  cant differences between wild-type and HD mice, 
except for decreased activity in the striatum of HD mice at 
12 mo of age (Fig. S4, available at http://www.jcb.org/cgi/
content/full/jcb.200709080/DC1). Although the biochemical 
assay for proteasomal activity is less sensitive than the fl  uo-
rescent reporter at detecting changes in the proteasomal activity 
in subcellular regions, this assay indicated that cortical synap-
tosomes from HD mice at 12 mo of age had decreased protea-
somal activity compared with samples from control littermates. 
However, the difference in cortical proteasomal activity is not 
statistically signifi  cant. Importantly, a statistically signifi  cant 
decrease in proteasomal activity was seen in synaptosomes from 
striatal neurons of HD knock-in mice and wild-type littermates at 
  Figure 6.       Accumulation of aggregated htt is cor-
related with the decrease in synaptic proteasome 
activity in R6/2 mouse brain.   (A) EM48 immuno-
staining showed more neuropil aggregates in 
R6/2 mice at 10 wk than at 4 wk. Bars, 10   μ  m. 
(B) Mouse brain extracts were fractionated to iso-
late cytosolic, nuclear, and synaptosomal fractions. 
Synaptosomal fraction is enriched for the synaptic 
protein synaptophysin but not the cytoplasmic 
protein GAPDH or the nuclear transcription factor 
TFIIB. Antibodies to proteasomal subunits LMP2, 
LMP7, and core subunits (a5, a7, b1, b5i, and b7) 
of 20S also detected the presence of these subunits 
in synaptosomes. (C) The chymotrypsin-like activity 
(mean + SEM,   n   = 4  –  5) of different fractions. (D) 
EM48 Western blotting showed more aggregated 
htt in synaptosomes (S) from younger mice at 4 wk 
of age. T: total lysates, C: cytosolic fraction, N: 
nuclear fraction. (E) The chymotrypsin-like activity 
(mean +SEM,   n   = 5  –  7) of total lysates (left) and 
synaptosomes (right) isolated from the striatum of 
R6/2 mice at 4 and 10 wk of age. Synaptosomal 
chymotrypsin-like activity in the striatum was lower 
than from the cortex, and synaptosomes isolated 
from HD brains also showed lower proteasomal 
activity than those from wild-type mouse brains. 
*, P   <   0.05 as compared with wild type.     JCB • VOLUME 180 • NUMBER 6 • 2008  1184
(  Fig. 8 A  , single arrows), which are likely to be degenerated 
mitochondria, in some axonal terminals containing htt aggregates 
(  Fig. 8 A  , double arrows). This fi  nding suggests that functional 
mitochondria could be reduced in the synapses of HD knock-
in mice. To better quantify the amount of mitochondria in the 
synapses of HD mice, we isolated synaptosomes and measured 
the level of the mitochondrial protein succinate dehydrogenase 
(SDH) by Western blotting. Compared with synaptosomes from 
wild-type mice at the same age (14 mo), there was a decrease in 
the SDH level in HD knock-in synaptosomes (  Fig. 8 B  ); how-
ever, the SDH levels in total cell lysates from wild-type and HD 
samples were no different. The decreased SDH level in HD syn-
aptosomes was also verifi  ed by the ratio of SDH to the synaptic 
protein syntaxin (  Fig. 8 C  ). Furthermore, by measuring the ATP 
content of striatal synaptosomes from wild-type and HD knock-
in mice at the age of 14 mo, we also observed a decrease in ATP 
levels in the HD samples (  Fig. 8 D  ). ATP levels in total cell 
lysates were     7-8  –  fold higher than in synaptosomes and were 
not signifi  cantly different between wild-type and HD samples, 
suggesting that mutant htt is more likely to affect ATP levels in 
synapses than in the cell body. Thus, a decrease in the amount of 
mitochondria and ATP in the synapses of HD mice may contrib-
ute to the reduced activity of synaptic UPS in HD mice. 
  Discussion 
  We generated adenoviral fl  uorescent reporters to measure syn-
aptic UPS activity in vitro and in vivo and observed a signifi  cant 
decrease in synaptic UPS activity in HD mice. These fi  ndings 
offer important insight into the synaptic dysfunction and selec-
tive neuropathology seen in HD. Furthermore, these new re-
porters can serve as a tool for measuring the function of the 
synaptic UPS and its regulation under normal physiological or 
pathological conditions. 
  Cell models and in vitro studies have shown that polyQ-
containing proteins can impair the activity of the UPS (  Bence 
et al., 2001  ;   Verhoef et al., 2002  ;   Venkatraman et al., 2004  ;   
Bennett et al., 2005  ). These studies have provided valuable in-
formation regarding the mechanisms by which polyQ proteins 
affect UPS function. Early studies suggested that protein aggre-
gation directly impairs the function of the UPS (  Bence et al., 
2001  ). It was also shown that the proteasome cannot digest 
and release polyQ-expanded peptides, which can impair the 
function of the proteasome (  Venkatraman et al., 2004  ). Recent 
studies demonstrate that misfolded polyQ proteins or fi  lamen-
tous mutant htt can directly affect the function of proteasomes 
before the formation of inclusions (  Bennett et al., 2005  ; 
 D í az-Hern á ndez  et  al.,  2006 ).  Although  these  studies  demon-
strate that mutant htt can directly impair proteasomal function, 
they were performed under in vitro conditions in which the lev-
els of mutant proteins might exceed the endogenous level of 
mutant protein in the HD brain. Thus, an important issue is 
whether UPS impairment also occurs in vivo. 
    Seo et al. (2004)   examined postmortem brain tissues of 
HD patients and observed a decrease in proteasomal activity in 
the striatum and cortex. However, this decrease could be due to 
atrophy or degeneration already present in the HD patient brains. 
  Figure 7.       Neuropil aggregates and synaptic UPS activity in HD knock-
in mouse brain.   (A) Immunostaining of heterozygous HD knock-in mice 
with the 1C2 antibody showing an increase in neuropil aggregates in 
the striatum with age. Bars, 10   μ  m. (B and C) Expression of presynaptic 
(SNAP25-GFPu/-RFP) (B) and postsynaptic (PSD95-GFP/-RFP) (C) reporters 
in the striatum of HD knock-in mice at 12 mo of age 7 d after injection of 
adenoviral UPS reporters. Note the increase in GFPu signals over time. 
Bars, 10   μ  m. (D) The ratios of GFPu to RFP in synapses (30  –  48 each group) 
of HD knock-in mice at 4, 8, and 12 mo of age were quantiﬁ  ed. **, P   <   
0.01. (E) Chymotrypsin-like proteasomal activity of synaptosomes isolated 
from the cortex and striatum of wild-type or heterozygous HD knock-in 
mice at 4, 8, and 12 mo of age. The data were obtained from ﬁ  ve ex-
periments and are represented as mean + SEM (  n   = 48). *, P   <   0.05 as 
compared with wild-type samples. The chymotrypsin-like activity of brain 
homogenates and post-glutamyl and trypsin-like activity of synaptosomes 
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activity in the HD brain (  Bennett et al., 2007  ). It is possible that 
the effect of polyQ proteins on UPS activity is dependent on its 
accumulation and subcellular localization, which cannot be de-
tected by examining whole cell homogenates. Because UPS ac-
tivity varies in different types of cells and in subcellular regions, 
it is important to evaluate UPS activity in different subcellular 
compartments of neurons, especially in synapses in which mu-
tant htt accumulates and affects neurotransmitter release or re-
ceptor function in the HD brain (  Usdin et al., 1999  ;   Cepeda 
et al., 2001  ;   Zeron et al., 2002  ;   Smith et al., 2005  ;   Cummings 
et al., 2006  ;   Fan et al., 2007  ). 
  Using adenoviral vectors that express synaptic fusion 
proteins containing fl  uorescent UPS reporters under the con-
trol of a neuronal promoter, we were able to target these re-
porters to presynaptic or postsynaptic terminals. Targeting of 
these reporters to defi  ned synaptic structures allows for sensi-
tive detection of changes in UPS activity at synapses. It is pos-
sible that GFPu can aggregate and that this aggregation renders 
  Figure 8.       Decreased synaptic ATP level in HD knock-
in mouse brain.   (A) Electron micrograph of EM48 
immunogold labeling of the striatum of a 12-mo-old HD 
150Q knock-in mouse brain. Arrows indicate degen-
erating mitochondria-like organelles. Double arrows 
indicate htt aggregates that were labeled by EM48 
immunogold particles. Bar, 250 nm. (B) Western blotting 
of total cell lysates (T), cytoplasmic (C), synaptosomal 
(S), and nuclear (N) fractions isolated from the brain 
of wild-type (WT) and HD 150Q knock-in (KI) mice at 
14 mo of age. The blots were probed with 1C2 for 
htt and antibodies to the mitochondrial protein SDH, 
the cytoplasmic protein GAPDH, the synaptic protein 
syntaxin, and the nuclear protein TBP. Arrow indicates 
full-length mutant htt. (C) Densitometry analysis of the 
ratio (mean + SEM,   n   = 3) of SDH to GAPDH or syn-
taxin. (D) ATP content (raw luminescence [A.U.]) in 
total cell lysates and synaptosomes isolated from the 
striatum of wild-type and HD KI mice at 12  –  14 mo of 
age. The data were presented as mean + SEM (  n   = 
5  –  6). *, P   <   0.05 as compared with wild type.     
A transgenic approach was used to express a fl  uorescent UPS 
reporter (UbG76V-GFP) in mice (  Lindsten et al., 2003  ). With 
this UPS reporter, mouse model was shown that prion pathol-
ogy causes impairment of the UPS in the brain (  Kristiansen 
et al., 2007)  . This transgenic mouse model led to the discovery 
that mutant polyQ proteins do not impair UPS activity in the 
retina of transgenic SCA7 mice (  Bowman et al., 2005  ). In addi-
tion, biochemical assays on brain homogenates from HD mice 
that express exon1 mutant htt did not reveal a reduction in 
proteasomal activity or the levels of proteasomal subunits LMP2 
and LMP7 in HD mice (  D  í  az-Hern  á  ndez et al., 2003  ;   Bett et al., 
2006  ). Instead, increased chymotrypsin-like activity was seen 
in whole brain homogenates of 13-wk-old R6/2 mice (  Bett 
et al., 2006 ) and in conditional HD (HD94) mice ( D í az-Hern  á ndez 
et al., 2003  ), which could be the indirect consequence of htt 
toxicity or cell stress. Nevertheless, measurement of polyubiq-
uitin chains revealed global changes in polyubiquitination 
in HD mouse brains, suggesting the presence of impaired UPS JCB • VOLUME 180 • NUMBER 6 • 2008  1186
 Another  fi  nding that supports the synaptic toxicity of 
mutant htt is the correlation between decreased synaptic UPS 
activity and the accumulation of mutant htt in synapses. 
Although this correlation suggests that mutant htt can impact 
UPS activity, additional factors might also infl  uence UPS ac-
tivity. In wild-type mice, synaptic UPS function decreases 
with age, suggesting that this age-dependent decrease in UPS 
activity can at least contribute to the age-dependent increase 
in synaptic htt aggregates. Interestingly, we have shown that 
proteasomal chymotrypsin-like activity in synapses is lower 
than in the cell bodies of mouse brains. Our previous studies 
also show that proteasome activity is lower in the nucleus than 
in the cytosolic fraction (  Zhou et al., 2003  ). Thus, the intrinsi-
cally lower activity of the proteasome in both the nucleus and 
synapses favors the preferential accumulation of mutant htt in 
these two subcellular regions. The preferential accumulation 
of mutant htt in synapses is probably also determined by other 
cellular factors, such as transport of htt to nerve terminals. 
As mutant htt also accumulates in the nucleus and affects gene 
expression, effects from both nuclear and cytoplasmic mutant 
htt can cause HD pathology. Because the synapses are a unique 
structure of neurons, the accumulation of mutant htt in this 
important site may be particularly relevant to the selective 
neuropathology seen in HD. 
 Our  fi  ndings also have implications for other neurological 
disorders.  In  Alzheimer ’ s  and  Parkinson ’ s  diseases,  synaptic 
dysfunction has been well documented (  Klyubin et al., 2005  ). 
Parkinson  ’  s disease is also characterized by the presence of 
Lewy bodies that are formed by     -synuclein, a protein that is 
abundant in synapses. UPS impairment is thought to be involved 
in the pathogenesis of these diseases ( Moore et al., 2003 ;  Bossy-
Wetzel et al., 2004  ;   Ross and Pickart, 2004  ), yet whether 
misfolded proteins can affect synaptic UPS function in these 
diseases remains to be investigated. Development of the synap-
tic UPS reporters in our study will help the investigation of 
synaptic function in these diseases, as well as other neuro-
logical disorders that may also involve synaptic dysfunction 
or UPS impairment. 
  Materials and methods 
  Antibodies and reagents 
  The rabbit polyclonal (EM48) and mouse monoclonal (mEM48) antibodies 
to htt were generated by using the ﬁ  rst 256 amino acids of human htt as 
described previously (  Gutekunst et al., 1999  ;   Zhou et al., 2003  ). 1C2, a 
mouse antibody to expanded polyQ tract, was obtained from Chemicon 
International. Other antibodies used for the following proteins were pur-
chased from commercial sources: GFP (Av monoclonal antibody 632380), 
DsRed (RFP) (Clontech Laboratories, Inc.), 20S proteasome subunit     1i 
(LMP2) and     5i (LMP7) (BIOMOL International, L.P.);     -tubulin and synap-
tophysin (Sigma-Aldrich); GAPDH, neuronal-speciﬁ   c nuclear protein 
(NeuN), and GFAP (Chemicon International); TFIIB (Santa Cruz Biotechnol-
ogy, Inc.); SNAP25 (Transduction Laboratories), PSD95 (Millipore), SDH 
(Invitrogen), Syntaxin (Sigma-Aldrich), TBP (Santa Cruz Biotechnology, 
Inc.), and rabbit anti-20S Proteasome Core Subunits (a5, a7, b1, b5i, and b7) 
(EMD). Hoechst 33258 was obtained from Invitrogen. 
  HD mice 
  R6/2 mice [B6CBA-TgN (HDexon1) 62], which express the ﬁ  rst  exon 
of human   Htt   (67 amino acids) with an additional 150-glutamine repeat 
(  Davies et al., 1997  ), were obtained from The Jackson Laboratory. HD 
150CAG repeat knock-in mice (HdhCAG150) expressing full-length mouse 
resistance to proteasomal degradation of GFPu. In cultured 
primary neurons, however, proteasomal inhibitors caused a 
more dramatic increase in the ratio of GFPu to RFP in syn-
apses than in the cell body (  Figs. 2 and 3  ). The selective local-
ization of these reporters in small synaptic structures allows 
for more reliable quantifi  cation of fl  uorescent signals than 
quantifi  cation of diffuse signals in the cell body. Accordingly, 
these reporters allowed us to detect for the fi  rst time synaptic 
UPS activity in the brain and also revealed decreased UPS ac-
tivity in the synapses of HD mouse brains. This decrease was 
confi  rmed by biochemical assays of proteasomal activity in 
isolated synaptosomes. Thus, the reporters we generated are 
effective in detecting synaptic UPS activity. Because these 
reporters can differentiate presynaptic and postsynaptic UPS 
activity, they will be valuable for the investigation of how pre-
synaptic or postsynaptic UPS function is regulated under 
physiological or pathological conditions. 
  Expression of the fl   uorescence UPS reporters in the 
defi  ned synaptic structure allowed us to uncover defective UPS 
activity in HD synapses. In addition to the direct effect of 
mutant htt on the UPS (  Venkatraman et al., 2004  ;   Bennett et al., 
2005  ), additional mechanisms may account for the effect of mu-
tant htt on synaptic UPS function. The activity of the UPS is 
critically dependent on mitochondrial ATP, and synaptic ATP 
levels are determined by the transport of mitochondria from the 
cell body to nerve terminals. Recent studies have demonstrated 
that mutant htt can impair the traffi  cking of mitochondria in 
neuronal processes (  Trushina et al., 2004  ;   Chang et al., 2006  ). 
Consistent with our earlier fi  ndings that degenerated mitochon-
dria were present in axonal terminals of R6/2 (  Yu et al., 2003  ) and 
HD 82Q KI (  Li et al., 2001  ) mice, degenerating mitochondria-
like organelles were also seen in the synapses of HD 150Q KI 
mice. Furthermore, we detected decreases in the levels of the 
mitochondrial protein SDH and ATP in synaptosomes from HD 
150Q KI mouse brain. Thus, the reduced ATP levels in synapses 
can lead to a defect in synaptic UPS function. In addition, the 
accumulation of mutant htt in synapses can promote its effect 
on synaptic mitochondria via other mechanisms. For example, 
mutant htt was found to reduce ATP levels by activating cas-
pases (  S  á  nchez et al., 2003  ), enhancing Ca 
2+   infl  ux through 
NMDA receptors (  Seong et al., 2005  ), and reducing mito-
chondrial respiratory function (  Milakovic and Johnson, 2005  ). 
All these effects could contribute to the preferential impairment 
of synaptic UPS function in HD mouse brains. 
  Because UPS activity is important in regulating the nor-
mal function and plasticity of synapses (  Yi and Ehlers, 2005  ; 
  Patrick 2006  ), decreased UPS activity may contribute to the 
synaptic dysfunction seen in HD mice. Previous studies have 
revealed the abnormal release of various neurotransmitters from 
synapses (  Usdin et al., 1999  ;   Cepeda et al., 2001  ;   Zeron et al., 
2002  ;   Cummings et al., 2006  ) and other defects, such as traf-
fi  cking of synaptic membrane receptors (  Fan et al., 2007  ), in 
HD mice, suggesting that mutant htt may have broad adverse 
effects on various aspects of synaptic function. Further investi-
gation of the relationship between postsynaptic or presynaptic 
UPS activity and synaptic htt should provide deeper insight into 
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Negative controls included the scrambled EGFP probe, hybridization buf-
fer only, and RNase A treatment of the sections before hybridization. 
  Fractionation 
  Subcellular fractions of mouse brain tissues were prepared using previ-
ously described methods (  Phillips et al., 2001  ). Cortical or striatal tissues 
from R6/2 or KI mice and control littermates were homogenized in 500   μ  l 
homogenization solution (0.32 M sucrose, 15 mM Tris-HCl pH 8.0, 60 mM 
KCl, 15 mM NaCl, 5 mM EDTA, 1 mM EGTA, and 2 mM ATP) at 4  °  C in 
an Eppendorf tube. The homogenate was centrifuged at 500   g   for 2 min 
to remove unbroken tissue clumps and cells. The supernatant (S1) was cen-
trifuged at 1,300   g   for 10 min to precipitate nuclei fraction (P1). The (S1) 
supernatant was transferred to another microfuge tube and centrifuged at 
10,000   g   for 10 min to obtain a mitochondria- and synaptosome-enriched 
pellet (P2) and the supernatant (S2). The (P2) pellet was resuspended in 
500   μ  l of 0.32 M sucrose and layered onto 750   μ  l of 0.8 M sucrose in a 
microfuge tube. The samples were centrifuged at 9,100   g   for 15 min using 
a swinging bucket rotor. The 0.8-M sucrose layer and most of the loose 
pellet containing the synaptosomes were collected and separated from the 
mitochondrial pellet. The (S2) supernatant was centrifuged at 13,000   g   for 
25 min to yield the supernatant (S3) or cytosolic fraction. 
  Proteasome activity assay 
  For determining proteasome activity, clear whole-cell extracts or cell frac-
tions were adjusted to 0.5 mg/ml total protein by dilution with homogeni-
zation buffer. All assays were done in triplicate. Chymotrypsin-like activity 
of 20S     5 was determined using the substrate Suc-LLVY-aminomethylcou-
marin (AMC) (40   μ  M; Bilmol), trypsin-like activity of 20S     2 was deter-
mined using the substrate Boc-LRR-AMC (Bilmol; 100   μ  M), and postglutamyl 
activity of 20S     1 was determined using the substrate Z-LLE-AMC (400   μ  M; 
Bilmol). Equal amounts (10   μ  g) of the extracts were incubated with corre-
sponding substrates in 100   μ  l proteasome activity assay buffer (0.05 M 
Tris-HCl, pH 8.0, 0.5 mM EDTA, 1 mM ATP, and 1 mM DTT) for 30  –  60 min 
at 37  °  C. The reactions were stopped by adding 0.8 ml of cold water and 
placing the reaction mixtures on ice for at least 10 min. The free AMC ﬂ  uo-
rescence was quantiﬁ   ed by using the CytoFluor multi-well plate reader 
(FLUOstar; BMG Labtech) with excitation and emission wavelengths at 380 
and 460 nm, respectively. All readings were standardized using the ﬂ  uo-
rescence intensity of an equal volume of free 7-amino-4-methyl-coumarin 
(AMC) solution (40 mM), normalized by the protein concentrations and ex-
pressed as nmol/min/mg protein. 
  ATP content assays 
  ATP levels were measured using a method described previously with minor 
modiﬁ  cations  (  Milakovic and Johnson, 2005  ) and a FLUOstar Galaxy 
microplate reader (BMG Labtech). Total cell lysates and synaptosomal frac-
tions, which were isolated form striata of wild-type and HD mouse brains 
and stored at     80  °  C until analysis for ATP content. Total (25   μ  g) and syn-
aptosomal (50   μ  g) samples were diluted to 50   μ  l with isolation buffer, 
added to 50   μ  l of Luciferase reaction buffer, and luminescence measured 
immediately. Each sample was analyzed in triplicate. Data are presented 
as raw luminescence (A.U.) + SEM. 
  Microscopy 
  All imaging was done at room temperature,     26  °  C. EM48 immunocyto-
chemical analysis of cultured cells and mouse brain tissues was performed 
as described previously (  Li et al., 2000  ,   Shin et al., 2005  ). Light micro-
graphs were taken using a microscope (Axiovert 200 MOT; Carl Zeiss, Inc.) 
equipped with a digital camera (Orca-100; Hamamatsu) and the image ac-
quisition software OpenLAB (Improvision). A 20x (LD-Achroplan 0.4 NA) or 
63x lens (0.75 NA) was used for light microscopy. Confocal imaging was 
performed using the 63x/1.4 NA oil immersion objective lens (Plan-
  apochromat) and an LSM 510 confocal microscope system (Carl Zeiss, Inc). 
For immunoﬂ  uorescent staining, species-speciﬁ  c ﬂ  uorescein- or Texas red  –
  conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) 
were applied for 1 h at room temperature followed by counterstaining with 
Hoechst dye. Enhanced GFP was imaged using 488-nm excitation and a 
500  –  530-nm band-pass ﬁ  lter, and RFP was imaged using 543-nm excita-
tion and a 565  –  615-nm band-pass ﬁ  lter. The ﬁ  gures were created using 
Photoshop 7.0 software (Adobe) and, in some cases, where the brightness 
and contrast of the whole image needed adjustment, we used the brightness/
contrast adjustment function. 
  Electron microscopic analysis of HD 150Q knock-in mouse brain tis-
sue was performed with EM48 according to previously published proce-
dures from our laboratory (  Li et al., 2000  ). In brief, brain sections were 
htt with an expanded polyglutamine repeat (150Q) (  Lin et al., 2001  ) were 
bred and maintained in the animal facility at Emory University as described 
previously (  Yu et al., 2003  ). Genotyping of transgenic mice was performed 
using methods described previously (  Yu et al., 2003  ). Heterozygous HD 
150CAG knock-in mice were used in the study. 
  Primary neuronal culture 
  Striatal and cortical neurons were isolated from E18 rat brains. Dissected 
tissues were treated with 0.0625 mg/ml trypsin in 1xHBSS buffer without 
calcium or magnesium for 10 min at 37  °  C followed by triturating with a 1 ml 
pipette tip 20 times. Cells were then washed once with the tissue culture 
medium and spun down at 500   g   for 3 min. Cells were plated on the glass 
coverslips that had been precoated with 0.1 mg/ml poly-  D  -lysine and 
1   μ  g/ml laminin, and grown initially in neurobasal/B27 medium following 
the method used in our previous study (  Li et al., 2000  ). To reduce glial pro-
liferation, 5   μ  M cytosine arabinoside was added 12  –  16 h after plating. 
  Adenoviral vector construction and preparation 
  A CL-1 degron sequence (  Bence et al., 2001  ) was added to the C terminus 
of GFP in the PRK vector to generate PRK-GFPu construct. cDNA sequences 
for DsRed (BD Biosciences) were used to replace GFPu to generate PRK-RFP 
construct. RT-PCR using RNAs from mouse brains was performed to isolate 
full-length cDNAs for mouse SNAP25 and PSD95. SNAP25 cDNA was iso-
lated with a sense primer 5    -acatcgatATGGCCGAAGACGCAGACATG-3     
and an antisense primer 5    -acacgcgtACCACTTCCCAGCATCTTTG-3    . Full 
length of PSD95 cDNA was isolated using the sense primer 5    -acatcgatC-
CAACATGGACTGTCTCTGTATAG-3     and the antisense primer 5    -atacgc-
gtGAGTCTCTCTCGGGCTGGGAC-3    . The PCR products were subcloned 
into the PRK-GFPu and PRK-RFP vectors to express fusion proteins that con-
tain GFPu or RFP at the C terminus of SNAP25 or PSD95. The DNA frag-
ments encoding these fusion proteins were inserted into the shuttle vector 
of the AdEasy vector system (Qbiogene). The CMV promoter was replaced 
by human synapsin-1 promoter provided by Dr. S. Kugler (University of 
Goettingen, Goettingen, Germany). Adenovirus ampliﬁ  cation and puriﬁ  ca-
tion were performed according to the method used in our previous study 
(  Shin et al., 2005  ). Viral titer was determined by measuring the number 
of infected HEK293 cells expressing GFPu or RFP. All viral stocks were 
adjusted to 10 
9   VP/ml. 
  Stereotaxic injection 
  HD mice described above and their wild-type littermates were used for this 
study. All experiments were performed in accordance with the National 
Institutes of Health (NIH) Guide for the Care and Use of Laboratory 
Animals and the Emory University Institutional Animal Care and Use Com-
mittee. In brief, mice were anesthetized with intraperitoneal injections of a 
combination of ketamine (90 mg/kg) and xylazine (13 mg/kg) and posi-
tioned in a stereotaxic apparatus. A small incision was made in the scalp, 
and the striatum was marked using the following stereotaxic coordinates, 
relative to Bregma: anterior  –  posterior +0.8 mm, medial  –  lateral     1.6 mm, 
and dorsal  –  ventral     3.3 mm. A small hole was drilled into the skull, and 
a 26-gauge needle attached to a 5-  μ  l Hamilton syringe was lowered into 
the striatum according to the dorsal  –  ventral coordinate. A nanoinjector 
pump (World Precision Instrument) controlled the infusion of 2.0   μ  l of 
adenovirus at a rate of 0.4   μ  l/min, after which the needle was left in place 
for 5 min to ensure complete diffusion of the viruses. The mice were exam-
ined by immunocytochemistry 7  –  8 d after injection. 
  In situ hybridization 
  The EGFP antisense oligonucleotide probe (5    -GGTGTCGCCCTCGAAC-
TTCACCTCGGCGCGGGTCTTGTAGTTGCC-3    ) and the control scrambled 
EGFP probe (5    -CGATGTTCTTGTGGCGGCTCGGCTTCCACCTCAAGCT-
GCCGTGG-3    ) were 3     end-labeled with digoxigenin-dUTP and dATP us-
ing the DIG-Tailing kit (Roche). The tailed probes were puriﬁ  ed by ethanol 
precipitation and detected by dot blot using a DIG Nucleic Acid Detection 
kit (Roche). Frozen brain tissues were cut and mounted onto microscope 
slides and ﬁ  xed with cold (4  °  C) 4% paraformaldehyde in 0.1 M PB solu-
tion. The sections were washed in 1  ×   PBS three times for 15 min, dipped 
quickly in water, dehydrated, and then air dried at least 2 h. Hybridiza-
tion buffer (50 ml of 4  ×   SSC, 20% dextran sulfate, 0.5  ×   Denhardts, 50% 
deionized formamide, 0.1 M DTT, 0.25 mg/ml poly A, 0.25 mg/ml tRNA, 
and 0.25mg/ml ssDNA) containing 500 ng/ml DIG-tailed oligo probe 
was applied to each section for incubation overnight at 39  °  C. The sections 
were sequentially washed in 1 and 0.5  ×   SSC/10 mM DTT at 55  °  C, buffer 
(0.1 M maleic acid, 0.15 M NaCl, pH 7.5). Anti-DIG-AP (1:300 dilution; 
Roche) and NBT/BCIP substrate were used to detect hybridization signals. JCB • VOLUME 180 • NUMBER 6 • 2008  1188
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incubated with EM48 in PBS containing 4% NGS for 24 h at 4  °  C and then 
with Fab fragments of goat anti  –  rabbit secondary antibodies (1:50) conju-
gated to 1.4-    m gold particles (Nanoprobes, Inc.) in PBS with 4% NGS 
overnight at 4  °  C. After rinsing in PBS, sections were ﬁ  xed again in 2% glu-
taraldehyde in PB for 1 h, silver intensiﬁ   ed using the IntenSEM kit (GE 
Healthcare; osmicated in 1% OsO  4   in PB, and stained overnight in 2% 
aqueous uranyl acetate). Sections used for electron microscopy were de-
hydrated in ascending concentrations of ethanol and propylene oxide/
Eponate 12 (1:1) and embedded in Eponate12 (Ted Pella). Ultrathin sections 
(60 nm) were cut using an ultramicrotome (Ultracut; Leica). Thin sections 
were counterstained with 5% aqueous uranyl acetate for 5 min followed by 
Reynolds lead citrate for 5 min and examined using an electron micro-
scope (H-7500; Hitachi). 
  Quantitative ﬂ  uorescence imaging analysis 
  Captured image ﬁ  les were loaded into the Image-Pro Plus (Media Cyber-
netics, Inc.) environment with the   ‘    ‘  count/size  ’    ’   function. Precise segmenta-
tion of bright spots was achieved by setting a lower threshold just above 
background emission, typically     23  –  25 grayscale units (gsu), and an up-
per threshold at the upper limit of the 8-bit grayscale (i.e., 255 gsu). Auto-
mated image analysis was performed with a custom-built algorithm. The 
algorithm performs a series of analyses on each image in both the red 
channel (for RFP) and the green channel (for GFPu) and then calculates 
quantitative output for ﬂ   uorescence intensity. The algorithm ﬁ  rst  corrects 
background if necessary and attempts to offset background anomalies. 
Cell bodies were detected as objects around the nuclei, separated from the 
neurites by a watershed ﬁ  lter. The next step in the algorithm locates syn-
apses. It starts by running a   “  Hi-Pass  ”   ﬁ  lter across the image to enhance 
edges (replaces each pixel with a value that increases contrast with neigh-
boring pixels) (  Mitchell et al., 2007  ). Synapses (40  –  75/each group) and 
cell bodies (7  –  9/each group) are selected as any objects with a size and 
signal intensity greater than a user-deﬁ  ned minimum that is above a de-
ﬁ  ned background. Image-Pro Plus generated a high-content array of mea-
surements that included event number, area, sum of pixel intensities, and 
maximum and minimum pixel intensities. The sum of pixel intensities is 
selected as the parameter for statistical analysis. 
  Statistical analysis 
  Statistical signiﬁ  cance (P   <   0.05) was assessed using the   t   test whenever 
two groups were compared. When analyzing multiple groups, we used 
ANOVA with Scheff  é    ’  s post hoc test to determine statistical signiﬁ  cance. 
Data are presented as mean + SE. Calculations were performed with 
SigmaPlot 4.11 and Prism (version 4) software. 
  Online supplemental material 
  Fig. S1 shows that Inhibition of proteasomal activity increases the GFPu 
level in neuronal cell bodies. Fig. S2 shows colocalization of SNAP25-
GFPu with neuropil htt aggregates in R6/2 mouse brain. Fig. S3 shows In 
situ hybridization analysis of the transcripts of SNAP25-GFPu in wild-type 
and R6/2 mouse brains. Fig. S4 shows chymotrypsin-like activities of the 
proteasome in whole cell extracts from the cortex or striatum of wild-type 
and HD knock-in mice. Fig. S5 shows post-glutamyl and trypsin-like activ-
ities of the synaptosomes isolated from the brain cortex or striatum of wild-
type and HD knock-in mice. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200709080/DC1. 
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